← All companies

BGM

BGM Group Ltd.

BGM Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.30

+0.01 +3.78%

Key statistics

from XBRL data in SEC filings

Market cap

$34.2M

Revenue (TTM)

$37.9M

Net income (TTM)

-$19.9M

EPS (TTM)

$-0.18

P/E ratio

—

Dividend yield

591893046.36%

Free cash flow

-$3.94M

Cash

$9.82M

Total assets

$434M

Gross margin

16.6%

52-week range

$0.25 – $11.80

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K FORM 6-K Jul 30, 2026 6-K FORM 6-K Jul 28, 2026 20-F Jul 21, 2026 6-K FORM 6-K Jul 13, 2026 6-K FORM 6-K Jun 17, 2026 6-K FORM 6-K Jun 9, 2026 6-K FORM 6-K May 18, 2026 6-K FORM 6-K May 7, 2026 6-K FORM 6-K Apr 30, 2026 6-K FORM 6-K Jan 29, 2026 6-K FORM 6-K Dec 22, 2025 6-K FORM 6-K Aug 14, 2025 6-K Jul 24, 2025 6-K FORM 6-K Jun 26, 2025 6-K FORM 6-K May 28, 2025 6-K FORM 6-K May 20, 2025 20-F/A May 8, 2025 6-K FORM 6-K May 6, 2025 6-K Apr 28, 2025 6-K FORM 6-K Apr 22, 2025 20-F/A Apr 3, 2025 6-K FORM 6-K Mar 28, 2025 6-K FORM 6-K Mar 19, 2025 6-K FORM 6-K Feb 28, 2025 20-F/A Feb 6, 2025 20-F Jan 27, 2025 6-K FORM 6-K Jan 7, 2025 6-K FORM 6-K Nov 29, 2024 6-K FORM 6-K Nov 27, 2024 6-K FORM 6-K Oct 22, 2024 6-K/A FORM 6-K/A Oct 10, 2024 6-K FORM 6-K Sep 9, 2024 6-K Aug 14, 2024 6-K FORM 6-K Jun 6, 2024 6-K FORM 6-K Jun 4, 2024 6-K Apr 25, 2024 6-K FORM 6-K Mar 11, 2024 20-F Feb 15, 2024 6-K Dec 20, 2023 6-K FORM 6-K Dec 7, 2023